Alcohol and liver;Alkohol und leber

Verdauungskrankheiten

Volumn 19, Issue 1, 2001, Pages 1-18

  Rossol, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alcohol; Cirrhosis; Fection; Hepatotoxicity; Viral coin

Indexed keywords

ALCOHOL; ANABOLIC AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; COLCHICINE; CORTICOSTEROID; CYTOKINE; GAMMA GLUTAMYLTRANSFERASE; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 8; OXANDROLONE; PENICILLAMINE; PHOSPHATIDYLCHOLINE; RIBAVIRIN; SILYMARIN; STEROID; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR;

ALCOHOL ABUSE; ALCOHOL LIVER CIRRHOSIS; CHRONIC LIVER DISEASE; COMORBIDITY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; REVIEW;

EID: 0035122406     PISSN: 0174738X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Increased plasma tumor necrosis factor in severe alcoholic hepatitis
2. Epidemiologie alkoholischer lebererkrankungen
3. Hepatitis B and C viruses in hepatitis B surface antigen-negative hepatocellular carcinoma patients
4. Interactions between alcohol and hepatitis viruses in the liver
5. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis
6. Pathologic der Hepatitis C
7. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
8. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
9. The role of hepatitis C virus in alcoholic liver disease
10. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis
11. Serum levels of interleukin-8 in alcoholic liver disease: Relationship with disease stage biochemical parameters and survival
12. Differences of liver membrane antibody frequency in alcoholic liver disease. Detection of IgG and IgA classes using radioimmunoassay
13. Epidemiology of alcoholic liver diesease
14. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis
15. Alcoholic liver disease: New insights in pathogenesis and treatments
16. Ethanol metabolism cirrhosis and alcoholism
17. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent
18. Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease
19. Epidemiology of hepatitis C among veterans with alcoholic liver disease. The VA Cooperative Study Group 275
20. A prospective study on hepatocellular carcinoma in liver cirrhosis: Respective roles of alcohol and hepatitis C virus infection
21. Alcoholic liver disease: Natural history, diagnosis, clinical features, evaluation, management, prognosis, and prevention
22. Helper-inducer and suppressor-inducer lymphocyte subsets in alcoholic cirrhosis
23. Alcohol and hepatitis C virus: The return of hepatotropic viruses
24. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity
25. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma - Its relationship to alcohol drinking and the age of transfusion
26. Interferon therapy for chronic hepatitis C in habitual drinkers: Comparison with chronic hepatitis C in infrequent drinkers
27. Effect of heavy alcohol intake on long-term results after curative resection of hepatitis C virus-related hepatocellular carcinoma
28. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers
29. Effect of alcohol consumption on serum hepatitis c virus RNA and histological lesions in chronic hepatitis C
30. Quantitative immunohistochemical analysis of lymphocyte subsets in alcoholic liver disease
31. Epidemiological aspects of alcoholic liver disease, ethanol metabolism, and pathogenesis of alcoholic liver injury
32. Spektrum alkoholischer lebererkrankungen
33. Tumor necrosis factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease
34. Hepatitis C and alcohol
35. Alcohol and liver fibrosis: Pathobiochemistry and treatment
36. Serummarker der leberfibrose
37. Hepatic fibrosis - Therapeutic strategies
38. Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis
39. Raised plasma soluble Fas and Fas ligand in alcoholic liver disease
40. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease
41. Clinical significance of hepatitis GB virus C infection in alcoholic liver disease
42. A histopathological study of alcoholics with chronic HCV infection: Comparison with chronic hepatitis C and alcoholic liver disease
43. Acetaldehyde/protein interactions: Are they involved in the pathogenesis of alcoholic liver disease?